Boc-Orn(Fmoc)-OH - China Factory, Suppliers, Manufacturers

Boc-Orn(Fmoc)-OH, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

Boc-Orn(Fmoc)-OH CAS 150828-96-9 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — Boc-Orn(Fmoc)-OH CAS 150828-96-9 Nα-Boc-Nδ-Fmoc-L-Ornithine Purity >99.0% (HPLC)
Read More

Boc-Orn(Fmoc)-OH CAS 150828-96-9 Nα-Boc-Nδ-Fmoc-L-Ornithine Purity >99.0% (HPLC)

Z-HomoPhe-OH CAS 127862-89-9 Assay ≥98.0% (HPLC)

Z-Ser-OH CAS 1145-80-8 N-Cbz-L-Serine Assay ≥99.0% (HPLC)

Z-Hyp-OH CAS 13504-85-3 Purity ≥99.0% (HPLC)

N-Cbz-N-Methyl-L-Isoleucine CAS 42417-66-3 Purity ≥98.0% (HPLC)

D-2-Cyanophenylalanine CAS 263396-41-4 Assay ≥98.0% (HPLC)

Top Selling Products

Related Blog
Reviews

The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

6 October 2021 The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2021 to Benjamin List Max-Planck-Institut für Kohlenforschung, Mülheim an der Ruhr, Germany Da...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...
Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...
Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Eqiupment: GC instrument (Shimadzu GC-2010) Column: DB-17 Agilent 30mX0.53mmX1.0μm Initial oven temperature: 80℃ Initial time 2.0min Rate ...
The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...

2022.09.16 06:45:35
2022.08.08 11:05:31
2022.07.06 08:29:09
2022.04.09 09:40:38
2022.03.27 11:29:51
2021.12.07 10:05:43

Boc-Orn(Fmoc)-OH - China Factory, Suppliers, Manufacturers

Related Products

Boc-Orn(Fmoc)-OH CAS 150828-96-9 Nα-Boc-Nδ-Fmoc-L-Ornithine Purity >99.0% (HPLC)

Boc-Orn(Fmoc)-OH CAS 150828-96-9 Nα-Boc-Nδ-Fmoc-L-Ornithine Purity >99.0% (HPLC)

Z-HomoPhe-OH CAS 127862-89-9 Assay ≥98.0% (HPLC)

Z-Ser-OH CAS 1145-80-8 N-Cbz-L-Serine Assay ≥99.0% (HPLC)

Z-Hyp-OH CAS 13504-85-3 Purity ≥99.0% (HPLC)

N-Cbz-N-Methyl-L-Isoleucine CAS 42417-66-3 Purity ≥98.0% (HPLC)

D-2-Cyanophenylalanine CAS 263396-41-4 Assay ≥98.0% (HPLC)

Top Selling Products

Crizotinib CAS 877399-52-5 Assay ≥99.0% API Factory High Quality

2-Bromo-4'-Benzyloxy-3'-Nitroacetophenone CAS 43229-01-2 Purity >98.0% (GC) Formoterol Fumarate Intermediate

Pyrrole-3-Carboxylic Acid CAS 931-03-3 Purity >98.0% (GC)

1-Bromo-3-Chloropropane CAS 109-70-6 Purity >99.5% (GC) Factory High Quality

N-Nitro-1,2,3,4-tetradehydro Argatroban Ethyl Ester CAS 74874-09-2 Purity ≥99.0% Argatroban Intermediate

2,5-Diamino-4,6-Dichloropyrimidine CAS 55583-59-0 Purity ≥98.0% (GC) Factory

4,6-Dichloro-5-Methoxypyrimidine CAS 5018-38-2 Purity ≥99.0% (HPLC) Factory Hot Sale

4-Amino-TEMPO Free Radical CAS 14691-88-4 Purity >98.0% (GC)

Fmoc-D-Ser-OH CAS 116861-26-8 N-Fmoc-D-Serine Purity >98.5% (HPLC)

Dibenzothiophene Sulfone CAS 1016-05-3 Purity >98.0% (GC) Factory High Quality

Benzoic Anhydride CAS 93-97-0 Assay ≥99.0% (HPLC) Factory

Boc-Glu(OFm)-OH CAS 123417-18-5 Purity >98.0% (HPLC)

The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

New COVID treatments offer hope

Xi presents award to top scientists

Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

The “Summit on COVID-19 Diagnostics & Treatment”

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

2022.09.16 06:45:35

2022.08.08 11:05:31

2022.07.06 08:29:09

2022.04.09 09:40:38

2022.03.27 11:29:51

2021.12.07 10:05:43

related search